153 related articles for article (PubMed ID: 37968804)
1. Food oral immunotherapy: Any distinguishing factors predicting the need of anti-IgE?
Akarcan SE; Şenol HD; Gülen F; Demir E
Allergol Immunopathol (Madr); 2023; 51(6):104-111. PubMed ID: 37968804
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of omalizumab-assisted desensitisation to cow's milk and eggs in patients refractory to conventional oral immunotherapy: real-life study.
Ayats-Vidal R; Riera-Rubió S; Valdesoiro-Navarrete L; García-González M; Larramona-Carrera H; Cruz OA; Bosque-García M
Allergol Immunopathol (Madr); 2022; 50(3):1-7. PubMed ID: 35527650
[TBL] [Abstract][Full Text] [Related]
3. Combining anti-IgE with oral immunotherapy.
Lin C; Lee IT; Sampath V; Dinakar C; DeKruyff RH; Schneider LC; Nadeau KC
Pediatr Allergy Immunol; 2017 Nov; 28(7):619-627. PubMed ID: 28782296
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of oral immunotherapy for the treatment of allergies.
Yanagida N; Sato S; Ebisawa M
Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis.
Zuberbier T; Wood RA; Bindslev-Jensen C; Fiocchi A; Chinthrajah RS; Worm M; Deschildre A; Fernandez-Rivas M; Santos AF; Jaumont X; Tassinari P
J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1134-1146. PubMed ID: 36529441
[TBL] [Abstract][Full Text] [Related]
6. Oral immunotherapy and potential treatment.
Sato S; Yanagida N; Ebisawa M
Chem Immunol Allergy; 2015; 101():106-13. PubMed ID: 26022870
[TBL] [Abstract][Full Text] [Related]
7. The Use of Omalizumab in Food Oral Immunotherapy.
Labrosse R; Graham F; Des Roches A; Bégin P
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):189-199. PubMed ID: 27628022
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.
Wood RA; Kim JS; Lindblad R; Nadeau K; Henning AK; Dawson P; Plaut M; Sampson HA
J Allergy Clin Immunol; 2016 Apr; 137(4):1103-1110.e11. PubMed ID: 26581915
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy.
Badina L; Belluzzi B; Contorno S; Bossini B; Benelli E; Barbi E; Berti I
Immun Inflamm Dis; 2022 Jan; 10(1):117-120. PubMed ID: 34623772
[TBL] [Abstract][Full Text] [Related]
11. Clinical studies in oral allergen-specific immunotherapy: differences among allergens.
Sato S; Yanagida N; Ogura K; Imai T; Utsunomiya T; Iikura K; Goto M; Asaumi T; Okada Y; Koike Y; Syukuya A; Ebisawa M
Int Arch Allergy Immunol; 2014; 164(1):1-9. PubMed ID: 24943470
[TBL] [Abstract][Full Text] [Related]
12. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
13. Oral Immunotherapy for Hazelnut Allergy: A Single-Center Retrospective Study on 100 Patients.
Moraly T; Pelletier de Chambure D; Verdun S; Preda C; Seynave M; Vilain AC; Chenivesse C; Delebarre-Sauvage C
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):704-709.e4. PubMed ID: 31751759
[TBL] [Abstract][Full Text] [Related]
14. Anti-immunoglobulin E for food allergy.
Dantzer JA; Wood RA
Ann Allergy Asthma Immunol; 2023 Jul; 131(1):11-22. PubMed ID: 37031775
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab as an adjuvant in food allergen immunotherapy.
Dantzer JA; Wood RA
Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):278-285. PubMed ID: 33605614
[TBL] [Abstract][Full Text] [Related]
16. Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients.
Azzano P; Paquin M; Langlois A; Morin C; Parizeault G; Lacombe-Barrios J; Samaan K; Graham F; Paradis L; Des Roches A; Bégin P
J Allergy Clin Immunol; 2021 Jan; 147(1):233-243. PubMed ID: 32980425
[TBL] [Abstract][Full Text] [Related]
17. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Guilleminault L; Michelet M; Reber LL
Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study.
Nachshon L; Goldberg MR; Levy MB; Appel MY; Epstein-Rigbi N; Lidholm J; Holmqvist M; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2019; 7(8):2775-2781.e2. PubMed ID: 31150789
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
[TBL] [Abstract][Full Text] [Related]
20. Double-Blind, Placebo-Controlled Study of E-B-FAHF-2 in Combination With Omalizumab-Facilitated Multiallergen Oral Immunotherapy.
Wang J; Wood RA; Raymond S; Suárez-Fariñas M; Yang N; Sicherer SH; Sampson HA; Li XM
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2208-2216.e1. PubMed ID: 37087097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
